• Reflect Scientific reported more than $1.4 million in delivered commercial freezer-system sales to six biopharmaceutical customers over nine months.
• Sales point to demand for its temperature-control technology in life-sciences markets with mission-critical low-temperature requirements.
• A provisional patent filing targets expansion into a blast plate freezer product line for additional biopharmaceutical applications.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reflect Scientific Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608120800PRIMZONEFULLFEED9808273) on August 12, 2026, and is solely responsible for the information contained therein.